ATE395363T1 - Monoklonale antikörper gegen das protein g3bp und deren verwendungen - Google Patents
Monoklonale antikörper gegen das protein g3bp und deren verwendungenInfo
- Publication number
- ATE395363T1 ATE395363T1 AT99925118T AT99925118T ATE395363T1 AT E395363 T1 ATE395363 T1 AT E395363T1 AT 99925118 T AT99925118 T AT 99925118T AT 99925118 T AT99925118 T AT 99925118T AT E395363 T1 ATE395363 T1 AT E395363T1
- Authority
- AT
- Austria
- Prior art keywords
- monoclonal antibodies
- g3bp
- protein
- protein g3bp
- concerns
- Prior art date
Links
- 101000893689 Homo sapiens Ras GTPase-activating protein-binding protein 1 Proteins 0.000 title abstract 2
- 102100040854 Ras GTPase-activating protein-binding protein 1 Human genes 0.000 title abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9807617A FR2780062B1 (fr) | 1998-06-17 | 1998-06-17 | Anticorps monoclonaux diriges contre la proteine g3bp, et leurs utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE395363T1 true ATE395363T1 (de) | 2008-05-15 |
Family
ID=9527481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99925118T ATE395363T1 (de) | 1998-06-17 | 1999-06-17 | Monoklonale antikörper gegen das protein g3bp und deren verwendungen |
Country Status (13)
Country | Link |
---|---|
US (1) | US7001980B1 (de) |
EP (1) | EP1087997B1 (de) |
JP (1) | JP2002518001A (de) |
KR (1) | KR100694917B1 (de) |
CN (1) | CN1213070C (de) |
AT (1) | ATE395363T1 (de) |
AU (1) | AU764139B2 (de) |
CA (1) | CA2331151A1 (de) |
DE (1) | DE69938725D1 (de) |
FR (1) | FR2780062B1 (de) |
HU (1) | HUP0103152A3 (de) |
IL (2) | IL139852A0 (de) |
WO (1) | WO1999065947A2 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001266070A1 (en) * | 2000-06-16 | 2001-12-24 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Method for identifying apoptosis-modified proteins |
CN1341644A (zh) * | 2000-09-07 | 2002-03-27 | 上海博德基因开发有限公司 | 一种新的多肽——人核内非均-核蛋白32.01和编码这种多肽的多核苷酸 |
AUPR721101A0 (en) * | 2001-08-23 | 2001-09-13 | University Of Queensland, The | Nucleic acid and polypeptide linked to breast cancer |
EP1514118A2 (de) * | 2002-06-20 | 2005-03-16 | EVOTEC Neurosciences GmbH | Diagnostische und therapeutische verwendung von ras-gtpase-aktivierendem sh3-bindendem protein 2 (g3bp2) für neurodegenerative erkrankungen |
EP1641820B1 (de) * | 2003-06-30 | 2008-05-28 | Université de Lausanne | Von rasgap-abgeleitetes peptid zur gezielten tötung von krebszellen |
MY157796A (en) | 2006-06-08 | 2016-07-29 | Chugai Pharmaceutical Co Ltd | Preventive or remedy for inflammatory disease |
ES2585480T3 (es) | 2007-12-05 | 2016-10-06 | Chugai Seiyaku Kabushiki Kaisha | Anticuerpo anti-NR10 y uso del mismo |
EP2475378B1 (de) * | 2009-09-10 | 2019-07-24 | Mayo Foundation For Medical Education And Research | Modulation von USP10 zur Verwendung bei der Behandlung von Krebs |
CN101921313B (zh) * | 2010-04-07 | 2012-02-29 | 武汉凯泰新生物技术有限公司 | 治疗或预防癌症的多肽或其衍生产品及应用 |
RU2013141079A (ru) | 2011-03-01 | 2015-04-10 | Ново Нордиск А/С | Антагонические лиганды dr3 |
BR112017022101A2 (pt) | 2015-04-14 | 2018-07-31 | Chugai Seiyaku Kabushiki Kaisha | composição farmacêutica para prevenção e/ou tratamento de dermatite atópica contendo antagonista de il-31 como ingrediente ativo |
CN106771258A (zh) * | 2017-02-16 | 2017-05-31 | 广州赛太特生物医学科技有限公司 | 一种半乳糖凝集素‑3结合蛋白的检测试剂盒及其方法和应用 |
WO2021100794A1 (ja) | 2019-11-20 | 2021-05-27 | 中外製薬株式会社 | 抗体含有製剤 |
CN113755594B (zh) * | 2021-09-26 | 2024-05-14 | 中国医学科学院肿瘤医院 | 一种预测小细胞肺癌辅助化疗获益和识别化疗耐药治疗靶点的系统和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5402648A (en) | 1993-07-01 | 1995-04-04 | Apd Cryogenics Inc. | Sealed dewar with separate circulation loop for external cooling at constant pressure |
IL116026A (en) * | 1994-11-22 | 2005-08-31 | Rhone Poulenc Rorer Sa | Peptides capable of linking to the sh3 domain of gap, nucleotide sequences encoding the same, their preparation and uses |
US5783186A (en) * | 1995-12-05 | 1998-07-21 | Amgen Inc. | Antibody-induced apoptosis |
US6252050B1 (en) * | 1998-06-12 | 2001-06-26 | Genentech, Inc. | Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method |
-
1998
- 1998-06-17 FR FR9807617A patent/FR2780062B1/fr not_active Expired - Fee Related
-
1999
- 1999-06-17 EP EP99925118A patent/EP1087997B1/de not_active Expired - Lifetime
- 1999-06-17 AU AU41515/99A patent/AU764139B2/en not_active Ceased
- 1999-06-17 US US09/719,758 patent/US7001980B1/en not_active Expired - Lifetime
- 1999-06-17 HU HU0103152A patent/HUP0103152A3/hu unknown
- 1999-06-17 KR KR1020007014316A patent/KR100694917B1/ko not_active IP Right Cessation
- 1999-06-17 CA CA002331151A patent/CA2331151A1/fr not_active Abandoned
- 1999-06-17 AT AT99925118T patent/ATE395363T1/de not_active IP Right Cessation
- 1999-06-17 WO PCT/FR1999/001453 patent/WO1999065947A2/fr active IP Right Grant
- 1999-06-17 JP JP2000554772A patent/JP2002518001A/ja active Pending
- 1999-06-17 DE DE69938725T patent/DE69938725D1/de not_active Expired - Fee Related
- 1999-06-17 IL IL13985299A patent/IL139852A0/xx active IP Right Grant
- 1999-06-17 CN CNB998074179A patent/CN1213070C/zh not_active Expired - Fee Related
-
2000
- 2000-11-23 IL IL139852A patent/IL139852A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR100694917B1 (ko) | 2007-03-14 |
WO1999065947A2 (fr) | 1999-12-23 |
EP1087997B1 (de) | 2008-05-14 |
WO1999065947A3 (fr) | 2000-02-24 |
FR2780062A1 (fr) | 1999-12-24 |
AU764139B2 (en) | 2003-08-14 |
KR20010052942A (ko) | 2001-06-25 |
IL139852A0 (en) | 2002-02-10 |
FR2780062B1 (fr) | 2000-07-28 |
EP1087997A2 (de) | 2001-04-04 |
HUP0103152A2 (hu) | 2001-12-28 |
US7001980B1 (en) | 2006-02-21 |
CN1213070C (zh) | 2005-08-03 |
HUP0103152A3 (en) | 2004-03-01 |
IL139852A (en) | 2006-04-10 |
CA2331151A1 (fr) | 1999-12-23 |
AU4151599A (en) | 2000-01-05 |
CN1305497A (zh) | 2001-07-25 |
JP2002518001A (ja) | 2002-06-25 |
DE69938725D1 (de) | 2008-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE470714T1 (de) | Antikörper gegen doppelintegrinen, zusammensetzungen, verfahren und verwendungen | |
ATE517125T1 (de) | ANTIKÖRPER GEGEN ßDEATH RECEPTOR 4ß (DR4) UND DEREN VERWENDUNGEN | |
ATE395363T1 (de) | Monoklonale antikörper gegen das protein g3bp und deren verwendungen | |
DK1356052T3 (da) | Produktion af hele antistoffer i prokaryotiske celler | |
EE200000642A (et) | Suurendatud saagisega FAPalfa-spetsiifilised antikehad | |
ATE354655T1 (de) | Humane antikörper gegen ctla-4 und deren verwendungen | |
ATE171473T1 (de) | Humanisierte monoklonale antikörper gegen humanes interleukin - 4 | |
TR200102877T2 (tr) | İmmünoglobulinin kendi yüksek afinite reseptörüne bağlanmasını inhibe eden antikorlara karşı anti-idiotipik antikorlar. | |
WO1999046379A3 (en) | Human receptor proteins; related reagents and methods | |
ATE362490T1 (de) | Monoklonale antikörper gegen den menschlichen ldl-rezeptor, deren herstellung und verwendung | |
ATE248189T1 (de) | Antikörper gegen vasp (vasodilator-stimulated phosphoprotein), hybridomzellen für deren gewinnung, und deren verwendung | |
DE69728897D1 (de) | Saeugetierchemokine | |
ATE189897T1 (de) | Antikörper gegen das prorenin profragment, reninaktive substanz die diese enthält und prorenintest die diese verwendet | |
DE3888604T2 (de) | Monoklonale Antikörper gegen Antithrombinbindende Substanz und seine Verwendungen. | |
CY1109583T1 (el) | Κυτοκινες θηλαστικων, αντιστοιχα αντιδραστηρια | |
ATE432292T1 (de) | Antitumorantikörper, proteine und deren verwendung | |
DE60045637D1 (de) | Nicotin-acetylcholin rezeptoruntereinheit, deren isolierung und verwendung | |
IT1301815B1 (it) | Anticorpi monoclonali umani contro l'antigene tumorale uk114 e cellulelinfocitarie e ibridomi per la loro produzione | |
IT1293510B1 (it) | Anticorpi monoclonali catalitici per la trasformazione in vivo di profarmaci di corticosteroidi | |
DE29508576U1 (de) | Antikörper gegen das 42kDa-Protein aus Säugerzellen und Testsysteme zur Tumordiagnostik | |
DE69836096D1 (de) | Anti-idiotypische monoklonale antikörper, deren verwendung zur aktiven immuntherapie bösartiger tumoren, und zusammensetzungen die diese enthalten | |
WO1999002564A3 (de) | Ancrod spezifische monoklonale antikörper, antikörperfragmente, deren mischungen oder derivate und deren verwendung | |
BR9815776A (pt) | Anticorpos monoclonais anti-tag-72 humanizados com alta afinidade | |
CY1114280T1 (el) | Αντισωματα ανταγωνιστων των κυτοκινων θηλαστικων ή οι υποδοχεις τους για την αγωγη της αλλεργιας | |
SE9404491D0 (sv) | Process for the production of human monoclonal antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |